U.S. Securities and Exchange Commission

 

Washington, D.C. 20549

 

Form 8-K
Current Report

 

Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

 

NOVEMBER 8, 2012
Date of Report (Date of earliest event Reported)

 

MESA LABORATORIES, INC.
(Exact Name of Small Business Issuer as Specified in its Charter)

 

Commission File Number: 0-11740

 

COLORADO (State or other Jurisdiction of Incorporation or Organization)

84-0872291 (I.R.S. Employer Identification No.)

12100 WEST SIXTH AVENUE, LAKEWOOD, COLORADO (Address of Principal Executive Offices)

80228 (Zip Code)

 

Issuer’s telephone number, including area code: (303) 987-8000

 

Not Applicable.
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

 

        Pursuant to the interim guidance provided in Release No. 33-8216, the disclosure being furnished in this Form 8-K is being furnished under Item 12, “Results of Operations and Financial Condition,” of form 8-K.

 

        On November 8, 2012, Mesa Laboratories, Inc. issued a press release describing its results of operations for its second quarter ended September 30, 2012. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

 

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

 

d)

Exhibits:

99.1 Press Release issued November 8, 2012

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

MESA LABORATORIES, INC. (Issuer)

 

DATED: November 8, 2012			BY:	/s/ John J. Sullivan, Ph.D.
				John J. Sullivan, Ph.D. Chief Executive Officer, President and Director

INDEX TO EXHIBITS

 

Exhibit No. 99.1

Description Press release dated November 8, 2012

Method of Filing Filed herewith